Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 129 entries
Sorted by: Best Match Show Resources per page
Updated birth prevalence and relative frequency of mucopolysaccharidoses across Brazilian regions.

Genetics and molecular biology

Josahkian JA, Trapp FB, Burin MG, Michelin-Tirelli K, Magalhães APPS, Sebastião FM, Bender F, Mari JF, Brusius-Facchin AC, Leistner-Segal S, Málaga DR, Giugliani R.
PMID: 33503199
Genet Mol Biol. 2021 Jan 27;44(1):e20200138. doi: 10.1590/1678-4685-GMB-2020-0138. eCollection 2021.

The mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by 11 enzyme deficiencies, classified into seven types. Data on the birth prevalence of each MPS type are available for only a few countries, and the totality of...

Cite
Josahkian JA, Trapp FB, Burin MG, et al. Updated birth prevalence and relative frequency of mucopolysaccharidoses across Brazilian regions. Genet Mol Biol. 2021;44(1):e20200138doi: 10.1590/1678-4685-GMB-2020-0138.
Josahkian, J. A., Trapp, F. B., Burin, M. G., Michelin-Tirelli, K., Magalhães, A. P. P. S., Sebastião, F. M., Bender, F., Mari, J. F., Brusius-Facchin, A. C., Leistner-Segal, S., Málaga, D. R., & Giugliani, R. (2021). Updated birth prevalence and relative frequency of mucopolysaccharidoses across Brazilian regions. Genetics and molecular biology, 44(1), e20200138. https://doi.org/10.1590/1678-4685-GMB-2020-0138
Josahkian, Juliana Alves, et al. "Updated birth prevalence and relative frequency of mucopolysaccharidoses across Brazilian regions." Genetics and molecular biology vol. 44,1 (2021): e20200138. doi: https://doi.org/10.1590/1678-4685-GMB-2020-0138
Josahkian JA, Trapp FB, Burin MG, Michelin-Tirelli K, Magalhães APPS, Sebastião FM, Bender F, Mari JF, Brusius-Facchin AC, Leistner-Segal S, Málaga DR, Giugliani R. Updated birth prevalence and relative frequency of mucopolysaccharidoses across Brazilian regions. Genet Mol Biol. 2021 Jan 27;44(1):e20200138. doi: 10.1590/1678-4685-GMB-2020-0138. eCollection 2021. PMID: 33503199; PMCID: PMC7839630.
Copy Download .nbib Format: NLM
Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study.

Journal of neurology, neurosurgery, and psychiatry

Buron MD, Kalincik T, Sellebjerg F, Sørensen PS, Magyari M.
PMID: 33436501
J Neurol Neurosurg Psychiatry. 2021 May;92(5):556-562. doi: 10.1136/jnnp-2020-324869. Epub 2021 Jan 12.

BACKGROUND: Switching between first-line disease-modifying therapies in patients with clinically stable relapsing-remitting multiple sclerosis (RRMS) due to reasons other than disease activity is frequent, but evidence on the effect of this practice is limited. We investigated the effect of...

Cite
Buron MD, Kalincik T, Sellebjerg F, et al. Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study. J Neurol Neurosurg Psychiatry. 2021;92(5):556-562doi: 10.1136/jnnp-2020-324869.
Buron, M. D., Kalincik, T., Sellebjerg, F., Sørensen, P. S., & Magyari, M. (2021). Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study. Journal of neurology, neurosurgery, and psychiatry, 92(5), 556-562. https://doi.org/10.1136/jnnp-2020-324869
Buron, Mathias Due, et al. "Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study." Journal of neurology, neurosurgery, and psychiatry vol. 92,5 (2021): 556-562. doi: https://doi.org/10.1136/jnnp-2020-324869
Buron MD, Kalincik T, Sellebjerg F, Sørensen PS, Magyari M. Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study. J Neurol Neurosurg Psychiatry. 2021 May;92(5):556-562. doi: 10.1136/jnnp-2020-324869. Epub 2021 Jan 12. PMID: 33436501.
Copy Download .nbib Format: NLM
Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder.

Pattern recognition

Liu S, Han J, Puyal EL, Kontaxis S, Sun S, Locatelli P, Dineley J, Pokorny FB, Costa GD, Leocani L, Guerrero AI, Nos C, Zabalza A, Sørensen PS, Buron M, Magyari M, Ranjan Y, Rashid Z, Conde P, Stewart C, Folarin AA, Dobson RJ, Bailón R, Vairavan S, Cummins N, Narayan VA, Hotopf M, Comi G, Schuller B, Consortium RC.
PMID: 34720200
Pattern Recognit. 2022 Mar;123:108403. doi: 10.1016/j.patcog.2021.108403. Epub 2021 Oct 26.

This study proposes a contrastive convolutional auto-encoder (contrastive CAE), a combined architecture of an auto-encoder and contrastive loss, to identify individuals with suspected COVID-19 infection using heart-rate data from participants with multiple sclerosis (MS) in the ongoing RADAR-CNS mHealth...

Cite
Liu S, Han J, Puyal EL, et al. Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder. Pattern Recognit. 2021;123:108403doi: 10.1016/j.patcog.2021.108403.
Liu, S., Han, J., Puyal, E. L., Kontaxis, S., Sun, S., Locatelli, P., Dineley, J., Pokorny, F. B., Costa, G. D., Leocani, L., Guerrero, A. I., Nos, C., Zabalza, A., Sørensen, P. S., Buron, M., Magyari, M., Ranjan, Y., Rashid, Z., Conde, P., Stewart, C., Folarin, A. A., Dobson, R. J., Bailón, R., Vairavan, S., Cummins, N., Narayan, V. A., Hotopf, M., Comi, G., Schuller, B., & Consortium, R. C. (2022). Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder. Pattern recognition, 123108403. https://doi.org/10.1016/j.patcog.2021.108403
Liu, Shuo, et al. "Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder." Pattern recognition vol. 123 (2022): 108403. doi: https://doi.org/10.1016/j.patcog.2021.108403
Liu S, Han J, Puyal EL, Kontaxis S, Sun S, Locatelli P, Dineley J, Pokorny FB, Costa GD, Leocani L, Guerrero AI, Nos C, Zabalza A, Sørensen PS, Buron M, Magyari M, Ranjan Y, Rashid Z, Conde P, Stewart C, Folarin AA, Dobson RJ, Bailón R, Vairavan S, Cummins N, Narayan VA, Hotopf M, Comi G, Schuller B, Consortium RC. Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder. Pattern Recognit. 2022 Mar;123:108403. doi: 10.1016/j.patcog.2021.108403. Epub 2021 Oct 26. PMID: 34720200; PMCID: PMC8547790.
Copy Download .nbib Format: NLM
Information and Diagnosis Networks - tools to improve diagnosis and treatment for patients with rare genetic diseases.

Genetics and molecular biology

Vieira TA, Trapp FB, Souza CFM, Faccini LS, Jardim LB, Schwartz IVD, Riegel M, Vargas CR, Burin MG, Leistner-Segal S, Ashton-Prolla P, Giugliani R.
PMID: 31188934
Genet Mol Biol. 2019;42(1):155-164. doi: 10.1590/1678-4685-GMB-2018-0214. Epub 2019 Jun 10.

Brazil is a country of continental dimensions and most genetic services are concentrated in the Southeast and South, including the Medical Genetics Service of the Hospital de Clínicas de Porto Alegre (MGS/HCPA). As many areas on the country do...

Cite
Vieira TA, Trapp FB, Souza CFM, et al. Information and Diagnosis Networks - tools to improve diagnosis and treatment for patients with rare genetic diseases. Genet Mol Biol. 2019;42(1):155-164doi: 10.1590/1678-4685-GMB-2018-0214.
Vieira, T. A., Trapp, F. B., Souza, C. F. M., Faccini, L. S., Jardim, L. B., Schwartz, I. V. D., Riegel, M., Vargas, C. R., Burin, M. G., Leistner-Segal, S., Ashton-Prolla, P., & Giugliani, R. (2019). Information and Diagnosis Networks - tools to improve diagnosis and treatment for patients with rare genetic diseases. Genetics and molecular biology, 42(1), 155-164. https://doi.org/10.1590/1678-4685-GMB-2018-0214
Vieira, Taiane Alves, et al. "Information and Diagnosis Networks - tools to improve diagnosis and treatment for patients with rare genetic diseases." Genetics and molecular biology vol. 42,1 (2019): 155-164. doi: https://doi.org/10.1590/1678-4685-GMB-2018-0214
Vieira TA, Trapp FB, Souza CFM, Faccini LS, Jardim LB, Schwartz IVD, Riegel M, Vargas CR, Burin MG, Leistner-Segal S, Ashton-Prolla P, Giugliani R. Information and Diagnosis Networks - tools to improve diagnosis and treatment for patients with rare genetic diseases. Genet Mol Biol. 2019;42(1):155-164. doi: 10.1590/1678-4685-GMB-2018-0214. Epub 2019 Jun 10. PMID: 31188934; PMCID: PMC6687351.
Copy Download .nbib Format: NLM
Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from .

Toxicology reports

Ballesteros-Ramírez R, Durán MI, Fiorentino S.
PMID: 33552924
Toxicol Rep. 2020 Dec 26;8:258-263. doi: 10.1016/j.toxrep.2020.12.024. eCollection 2021.

The standardized P2Et extract obtained from

Cite
Ballesteros-Ramírez R, Durán MI, Fiorentino S. Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from . Toxicol Rep. 2020;8:258-263doi: 10.1016/j.toxrep.2020.12.024.
Ballesteros-Ramírez, R., Durán, M. I., & Fiorentino, S. (2021). Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from . Toxicology reports, 8258-263. https://doi.org/10.1016/j.toxrep.2020.12.024
Ballesteros-Ramírez, R, et al. "Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from ." Toxicology reports vol. 8 (2021): 258-263. doi: https://doi.org/10.1016/j.toxrep.2020.12.024
Ballesteros-Ramírez R, Durán MI, Fiorentino S. Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from . Toxicol Rep. 2020 Dec 26;8:258-263. doi: 10.1016/j.toxrep.2020.12.024. eCollection 2021. PMID: 33552924; PMCID: PMC7847824.
Copy Download .nbib Format: NLM
Exfoliative cytology of the colon.

Proceedings of the Royal Society of Medicine

BURN JI.
PMID: 13874936
Proc R Soc Med. 1961 Sep;54:726-9.

No abstract available.

Cite
BURN JI. Exfoliative cytology of the colon. Proc R Soc Med. 1961;54:726-9
BURN, J. I. (1961). Exfoliative cytology of the colon. Proceedings of the Royal Society of Medicine, 54726-9.
BURN, J I. "Exfoliative cytology of the colon." Proceedings of the Royal Society of Medicine vol. 54 (1961): 726-9.
BURN JI. Exfoliative cytology of the colon. Proc R Soc Med. 1961 Sep;54:726-9. PMID: 13874936; PMCID: PMC1870549.
Copy Download .nbib Format: NLM
The Role of FDG-PET in Diagnosing Suspected Tumor Recurrence Based on Increased Levels of Plasma Markers.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T

Maldonado A, Sancho F, Calvo FA, López N, Carrión RP, Barón MG, Trampal C, Ortega F.
PMID: 14516569
Clin Positron Imaging. 1998 Sep;1(4):246. doi: 10.1016/s1095-0397(98)00036-3.

No abstract available.

Cite
Maldonado A, Sancho F, Calvo FA, et al. The Role of FDG-PET in Diagnosing Suspected Tumor Recurrence Based on Increased Levels of Plasma Markers. Clin Positron Imaging. 1998;1(4):246doi: 10.1016/s1095-0397(98)00036-3.
Maldonado, A., Sancho, F., Calvo, F. A., López, N., Carrión, R. P., Barón, M. G., Trampal, C., & Ortega, F. (1998). The Role of FDG-PET in Diagnosing Suspected Tumor Recurrence Based on Increased Levels of Plasma Markers. Clinical positron imaging : official journal of the Institute for Clinical P.E.T, 1(4), 246. https://doi.org/10.1016/s1095-0397(98)00036-3
Maldonado, A, et al. "The Role of FDG-PET in Diagnosing Suspected Tumor Recurrence Based on Increased Levels of Plasma Markers." Clinical positron imaging : official journal of the Institute for Clinical P.E.T vol. 1,4 (1998): 246. doi: https://doi.org/10.1016/s1095-0397(98)00036-3
Maldonado A, Sancho F, Calvo FA, López N, Carrión RP, Barón MG, Trampal C, Ortega F. The Role of FDG-PET in Diagnosing Suspected Tumor Recurrence Based on Increased Levels of Plasma Markers. Clin Positron Imaging. 1998 Sep;1(4):246. doi: 10.1016/s1095-0397(98)00036-3. PMID: 14516569.
Copy Download .nbib Format: NLM
Do State Laws Protecting Older Workers from Discrimination Reduce Age Discrimination in Hiring? Evidence from a Field Experiment.

The Journal of law & economics

Neumark D, Burn I, Button P, Chehras N.
PMID: 32051647
J Law Econ. 2019 May;62(2):373-402. doi: 10.1086/704008.

We conduct a resume field experiment in all U.S. states to study how state laws protecting older workers from age discrimination affect age discrimination in hiring for retail sales jobs. We relate the difference in callback rates between old...

Cite
Neumark D, Burn I, Button P, et al. Do State Laws Protecting Older Workers from Discrimination Reduce Age Discrimination in Hiring? Evidence from a Field Experiment. J Law Econ. 2019;62(2):373-402doi: 10.1086/704008.
Neumark, D., Burn, I., Button, P., & Chehras, N. (2019). Do State Laws Protecting Older Workers from Discrimination Reduce Age Discrimination in Hiring? Evidence from a Field Experiment. The Journal of law & economics, 62(2), 373-402. https://doi.org/10.1086/704008
Neumark, David, et al. "Do State Laws Protecting Older Workers from Discrimination Reduce Age Discrimination in Hiring? Evidence from a Field Experiment." The Journal of law & economics vol. 62,2 (2019): 373-402. doi: https://doi.org/10.1086/704008
Neumark D, Burn I, Button P, Chehras N. Do State Laws Protecting Older Workers from Discrimination Reduce Age Discrimination in Hiring? Evidence from a Field Experiment. J Law Econ. 2019 May;62(2):373-402. doi: 10.1086/704008. PMID: 32051647; PMCID: PMC7015261.
Copy Download .nbib Format: NLM
Opportunities and Limitations of Crop Phenotyping in Southern European Countries.

Frontiers in plant science

Costa JM, Marques da Silva J, Pinheiro C, Barón M, Mylona P, Centritto M, Haworth M, Loreto F, Uzilday B, Turkan I, Oliveira MM.
PMID: 31608085
Front Plant Sci. 2019 Sep 25;10:1125. doi: 10.3389/fpls.2019.01125. eCollection 2019.

The Mediterranean climate is characterized by hot dry summers and frequent droughts. Mediterranean crops are frequently subjected to high evapotranspiration demands, soil water deficits, high temperatures, and photo-oxidative stress. These conditions will become more severe due to global warming...

Cite
Costa JM, Marques da Silva J, Pinheiro C, et al. Opportunities and Limitations of Crop Phenotyping in Southern European Countries. Front Plant Sci. 2019;10:1125doi: 10.3389/fpls.2019.01125.
Costa, J. M., Marques da Silva, J., Pinheiro, C., Barón, M., Mylona, P., Centritto, M., Haworth, M., Loreto, F., Uzilday, B., Turkan, I., & Oliveira, M. M. (2019). Opportunities and Limitations of Crop Phenotyping in Southern European Countries. Frontiers in plant science, 101125. https://doi.org/10.3389/fpls.2019.01125
Costa, Joaquim Miguel, et al. "Opportunities and Limitations of Crop Phenotyping in Southern European Countries." Frontiers in plant science vol. 10 (2019): 1125. doi: https://doi.org/10.3389/fpls.2019.01125
Costa JM, Marques da Silva J, Pinheiro C, Barón M, Mylona P, Centritto M, Haworth M, Loreto F, Uzilday B, Turkan I, Oliveira MM. Opportunities and Limitations of Crop Phenotyping in Southern European Countries. Front Plant Sci. 2019 Sep 25;10:1125. doi: 10.3389/fpls.2019.01125. eCollection 2019. PMID: 31608085; PMCID: PMC6774291.
Copy Download .nbib Format: NLM
Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β.

Multiple sclerosis and related disorders

Buron MD, Magyari M, Chalmer TA, Sørensen PS, Sellebjerg F.
PMID: 31884382
Mult Scler Relat Disord. 2019 Dec 16;39:101894. doi: 10.1016/j.msard.2019.101894. Epub 2019 Dec 16.

BACKGROUND: Some patients with multiple sclerosis who are treated with interferon-β(IFNβ) develop neutralizing antibodies (NAbs), which reduce or abolish the therapeutic effects of the treatment. These patients are usually switched to a non-IFNβ treatment, such as glatiramer acetate (GA)....

Cite
Buron MD, Magyari M, Chalmer TA, et al. Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β. Mult Scler Relat Disord. 2019;39:101894doi: 10.1016/j.msard.2019.101894.
Buron, M. D., Magyari, M., Chalmer, T. A., Sørensen, P. S., & Sellebjerg, F. (2019). Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β. Multiple sclerosis and related disorders, 39101894. https://doi.org/10.1016/j.msard.2019.101894
Buron, Mathias Due, et al. "Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β." Multiple sclerosis and related disorders vol. 39 (2019): 101894. doi: https://doi.org/10.1016/j.msard.2019.101894
Buron MD, Magyari M, Chalmer TA, Sørensen PS, Sellebjerg F. Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β. Mult Scler Relat Disord. 2019 Dec 16;39:101894. doi: 10.1016/j.msard.2019.101894. Epub 2019 Dec 16. PMID: 31884382.
Copy Download .nbib Format: NLM
Reversing Urethral Hypovascularity Through Testosterone and Estrogen Supplementation.

Urology

Yura EM, Bury MI, Chan Y, Morey AF, Sharma AK, Hofer MD.
PMID: 32890623
Urology. 2020 Dec;146:242-247. doi: 10.1016/j.urology.2020.06.103. Epub 2020 Sep 03.

OBJECTIVE: To determine the ability of testosterone and estrogen to reverse urethral hypovascularity secondary to hypogonadism, we analyzed the effects of testosterone and estrogen supplementation on castrated Sprague Dawley rats.MATERIALS AND METHODS: Twenty four Sprague-Dawley rats were divided into...

Cite
Yura EM, Bury MI, Chan Y, et al. Reversing Urethral Hypovascularity Through Testosterone and Estrogen Supplementation. Urology. 2020;146:242-247doi: 10.1016/j.urology.2020.06.103.
Yura, E. M., Bury, M. I., Chan, Y., Morey, A. F., Sharma, A. K., & Hofer, M. D. (2020). Reversing Urethral Hypovascularity Through Testosterone and Estrogen Supplementation. Urology, 146242-247. https://doi.org/10.1016/j.urology.2020.06.103
Yura, Emily M, et al. "Reversing Urethral Hypovascularity Through Testosterone and Estrogen Supplementation." Urology vol. 146 (2020): 242-247. doi: https://doi.org/10.1016/j.urology.2020.06.103
Yura EM, Bury MI, Chan Y, Morey AF, Sharma AK, Hofer MD. Reversing Urethral Hypovascularity Through Testosterone and Estrogen Supplementation. Urology. 2020 Dec;146:242-247. doi: 10.1016/j.urology.2020.06.103. Epub 2020 Sep 03. PMID: 32890623.
Copy Download .nbib Format: NLM
Effect of oxodipine on calcium transport in isolated hepatocytes and rat liver mitochondria at different ages.

Archives of gerontology and geriatrics

Roncero I, Buron I, de la Cruz MJ.
PMID: 15374465
Arch Gerontol Geriatr. 1991 Jan-Feb;12(1):59-69. doi: 10.1016/0167-4943(91)90008-e.

Electron microscopy and biochemical studies were carried out in hepatocytes and mitochondria isolated from livers of young (3-6 month) and old (20-24 month) rats to know under which conditions oxodipine, a calcium antagonist, affects calcium metabolism, the mitochondrial morphology...

Cite
Roncero I, Buron I, de la Cruz MJ. Effect of oxodipine on calcium transport in isolated hepatocytes and rat liver mitochondria at different ages. Arch Gerontol Geriatr. 1991;12(1):59-69doi: 10.1016/0167-4943(91)90008-e.
Roncero, I., Buron, I., & de la Cruz, M. J. (1991). Effect of oxodipine on calcium transport in isolated hepatocytes and rat liver mitochondria at different ages. Archives of gerontology and geriatrics, 12(1), 59-69. https://doi.org/10.1016/0167-4943(91)90008-e
Roncero, I, et al. "Effect of oxodipine on calcium transport in isolated hepatocytes and rat liver mitochondria at different ages." Archives of gerontology and geriatrics vol. 12,1 (1991): 59-69. doi: https://doi.org/10.1016/0167-4943(91)90008-e
Roncero I, Buron I, de la Cruz MJ. Effect of oxodipine on calcium transport in isolated hepatocytes and rat liver mitochondria at different ages. Arch Gerontol Geriatr. 1991 Jan-Feb;12(1):59-69. doi: 10.1016/0167-4943(91)90008-e. PMID: 15374465.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 129 entries